e27200455914.qxnhwFJ7iTuNIG5MbaIsSXzzVUn0C_Jl8rWh1dcUBkA.-WuVgRky5VXEcw06B_cVDEmpHnC4YoEJkcTxk-ckcw_CdamUNx2wTep6GQ
09/12/09 Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin PU
12/12/12 Amylin Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation BU
09/12/09 Amylin Pharmaceuticals, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc. PR
07/12/07 Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. BU
04/12/04 Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. PR
03/12/03 Amylin Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Amylin Pharmaceuticals, Inc. BU
02/12/02 Amylin Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation BU
02/12/02 Amylin Pharmaceuticals, Inc. : Rigrodsky & Long, P.A. Announces Investigation Of Amylin Pharmaceuticals, Inc. Buyout BU
26/12/26 Amylin Pharmaceuticals, Inc. : New Clinical Data Analyses Show Metreleptin Reduced Blood Glucose and Triglyceride Levels in Patients with Rare Forms of Lipodystrophy BU
09/12/09 Amylin Pharmaceuticals, Inc. : SYMLIN® Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range BU
09/12/09 Amylin Pharmaceuticals, Inc. : BYETTA® Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes BU
05/12/05 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Present Data on BYDUREON™, BYETTA® and SYMLIN® at the American Diabetes Association 2012 Meeting BU
30/12/30 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference and Goldman Sachs 33rd Annual Global Healthcare Conference BU
09/12/09 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders BU
01/12/01 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference BU
26/12/26 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results BU
20/12/20 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Webcast First Quarter Results BU
10/12/10 Amylin Pharmaceuticals, Inc. : Icahn sues Amylin, pushes for sale RE
03/12/03 Amylin Pharmaceuticals, Inc. : Amylin Completes Biologics License Application for Metreleptin to Treat Diabetes and/or Hypertriglyceridemia in Patients With Rare Forms of Lipodystrophy PR
28/12/28 Amylin Pharmaceuticals, Inc. : Amylin rejected $3.5 billion Bristol offer: Bloomberg RE
23/12/23 Amylin Pharmaceuticals, Inc. : BYETTA® Approved for Use with Basal Insulin in Europe PU
08/12/08 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR
08/12/08 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference PR
08/12/08 Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals Announces Public Offering of Common Stock PR
29/12/29 Amylin Pharmaceuticals, Inc. : Amylin Supports Rare Disease Day 2012 PR

Become a member to access more news

New member
No results match your criteria
  1. Stock Market
  2. Stocks
  3. Stock
  4. News Amylin Pharmaceuticals LLC